Manufacturer
BAYER PHARMA AG
Contents
Aflibercept
Indication
Metastatic colorectal cancer, Macular oedema secondary to retinal vein occlusion, Diabetic macular oedema, Neovascular (wet) age-related macular degeneration, Choroidal neovascularisation secondary to pathologic myopia
Instruction
IV infusion: Dilute w/ glucose 5% or NaCl 0.9% to provide a soln containing 0.6-8 mg/mL.
Drug interaction
Not known
Malaysia
